Treatment with recombinant human erythropoietin induces a moderate rise in hematocrit and thrombin antithrombin in healthy subjects

Bleeding and thrombosis in the myeloproliferative disorders

AI Schafer · Blood · 1984 · 428 citations · Full text

Medicine, Hematology, Internal Medicine +11

Association between recombinant human erythropoietin and quality of life and exercise capacity of patients receiving haemodialysis. Canadian Erythropoietin Study Group.

Andreas Laupacis, E. M. I. Williams, Lisa Jones et al. · BMJ · 1990 · 426 citations · Full text

Medicine, Nephrology, Pharmacotherapy +14

An immunoassay for human D dimer using monoclonal antibodies

D.B. Rylatt, Andrea Blake, L.E. Cottis et al. · Thrombosis Research · 1983 · 312 citations

Life Sciences, Biotechnology, Immunology +9

Studies of the prothrombin activation pathway utilizing radioimmunoassays for the F2/F1 + 2 fragment and thrombin--antithrombin complex

JM Teitel, KA Bauer, HK Lau et al. · Blood · 1982 · 263 citations · Full text

Medicine, Biochemistry, Hematology +10

Determination of tissue plasminogen activator and its "fast" inhibitor in plasma.

Joanna Chmielewska, B. Wiman · Clinical Chemistry · 1986 · 184 citations · Full text

Pharmacy, Pharmaceutical Analysis, Biopharmaceutics +8